Download Reaxys Database Information

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript 
Indian Journal of Gastroenterology
Volume 27, Issue 1, January 2008, Pages 33-34
An audit of combined modality therapy for esophageal
squamous cell carcinoma from a teaching hospital in Iran (
Letter )
Toosi, M.S.a, Anvari, K.ac , Aledavood, A.a, Nowferesti, G.a, Mohtashami, S.b
a Department of Radiotherapy Oncology, Cancer Research Center, Mashhad University of Medical Sciences,
Mashhad, Iran
b Department of Medicine, Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
c Department of Radiotherapy Oncology, Omid Hospital, Kohsangi St., Mashhad, Iran
View references (7)
Abstract
[No abstract available]
Reaxys Database Information
|
Indexed Keywords
EMTREE drug terms: cisplatin; fluorouracil
EMTREE medical terms: adjuvant therapy; bone metastasis; cancer adjuvant therapy; cancer chemotherapy; cancer
radiotherapy; cancer recurrence; cancer staging; computer assisted tomography; disease free survival; echography;
esophageal squamous cell carcinoma; esophagus resection; febrile neutropenia; human; Iran; letter; liver metastasis;
lung metastasis; lymph node metastasis; multimodality cancer therapy; teaching hospital; thorax radiography
MeSH: Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Hospitals, Teaching;
Humans; Iran; Medical Audit
Medline is the source for the MeSH terms of this document.
Chemicals and CAS Registry Numbers: cisplatin, 15663-27-1, 26035-31-4, 96081-74-2; fluorouracil, 51-21-8
ISSN: 02548860 CODEN: IJOGDSource Type: Journal Original language: English
PubMed ID: 18541937Document Type: Letter
Related documents